Pendrin function in airway epithelia

Cellular Physiology and Biochemistry

Volumn 28, Issue 3, 2011, Pages 571-578

  Nofziger, Charity ^a   Dossena, Silvia ^a   Suzuki, Shoichi ^b   Izuhara, Kenji ^b   Paulmichl, Markus ^a  

^a PARACELSUS MEDICAL UNIVERSITY   (Austria)

^b SAGA UNIVERSITY   (Japan)

Author keywords

Asthma; Chronic obstructive pulmonary disease; Cytokine; Interleukin; Mucus; Pendred syndrome; Sensorineural hearing loss; SLC26A4

Indexed keywords

ANTIASTHMATIC AGENT; AS 1517499; BAY 16 9996; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; CYTOKINE; INTERLEUKIN 13; INTERLEUKIN 4; LEBRIKIZUMAB; MEPOLIZUMAB; PENDRIN; PITRAKINRA; RESLIZUMAB; STAT6 PROTEIN; UNCLASSIFIED DRUG;

AIRWAY; ANION EXCHANGE; ASTHMA; BRONCHUS MUCOSA; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE SEVERITY; DRUG TARGETING; HUMAN; IMMUNE RESPONSE; INFLAMMATION; LUNG FUNCTION; NONHUMAN; PENDRED SYNDROME; PERCEPTION DEAFNESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESPIRATORY EPITHELIUM; REVIEW; TREATMENT OUTCOME;

EID: 82255167090     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000335115     Document Type: Review

References (70)

1. Mount DB, Romero MF: The SLC26 gene family of multifunctional anion exchangers. Pflugers Arch 2004;447:710-721. (Pubitemid 38241456)
2. Royaux IE, Suzuki K, Mori A, Katoh R, Everett LA, Kohn LD, Green ED: Pendrin, the protein encoded by the Pendred syndrome gene (PDS), is an apical porter of iodide in the thyroid and is regulated by thyroglobulin in FRTL-5 cells. Endocrinology 2000;141:839-845. (Pubitemid 32250509)
3. Scott DA, Wang R, Kreman TM, Sheffield VC, Karniski LP: The Pendred syndrome gene encodes a chloride-iodide transport protein. Nat Genet 1999;21:440-443. (Pubitemid 29159585)
4. Royaux IE, Wall SM, Karniski LP, Everett LA, Suzuki K, Knepper MA, Green ED: Pendrin, encoded by the Pendred syndrome gene, resides in the apical region of renal intercalated cells and mediates bicarbonate secretion. Proc Natl Acad Sci USA 2001;98:4221-4226. (Pubitemid 32249925)
5. Lacroix L, Mian C, Caillou B, Talbot M, Filetti S, Schlumberger M, Bidart JM: Na+/I-symporter and Pendred syndrome gene and protein expressions in human extra-thyroidal tissues. Eur J Endocrinol 2001;144:297-302. (Pubitemid 32266301)
6. Di Valentin E, Crahay C, Garbacki N, Hennuy B, Gueders M, Noel A, Foidart JM, Grooten J, Colige A, Piette J, Cataldo D: New asthma biomarkers: Lessons from murine models of acute and chronic asthma. Am J Physiol Lung Cell Mol Physiol 2009;296:L185-197.
7. Kuperman DA, Lewis CC, Woodruff PG, Rodriguez MW, Yang YH, Dolganov GM, Fahy JV, Erle DJ: Dissecting asthma using focused transgenic modeling and functional genomics. J Allergy Clin Immunol 2005;116:305-311. (Pubitemid 41096536)
8. Nakagami Y, Favoreto S, Jr., Zhen G, Park SW, Nguyenvu LT, Kuperman DA, Dolganov GM, Huang X, Boushey HA, Avila PC, Erle DJ: The epithelial anion transporter pendrin is induced by allergy and rhinovirus infection, regulates airway surface liquid, and increases airway reactivity and inflammation in an asthma model. J Immunol 2008;181:2203-2210.
9. Nakao I, Kanaji S, Ohta S, Matsushita H, Arima K, Yuyama N, Yamaya M, Nakayama K, Kubo H, Watanabe M, Sagara H, Sugiyama K, Tanaka H, Toda S, Hayashi H, Inoue H, Hoshino T, Shiraki A, Inoue M, Suzuki K, Aizawa H, Okinami S, Nagai H, Hasegawa M, Fukuda T, Green ED, Izuhara K: Identification of pendrin as a common mediator for mucus production in bronchial asthma and chronic obstructive pulmonary disease. J Immunol 2008;180:6262-6269.
10. Nofziger C, Vezzoli V, Dossena S, Schonherr T, Studnicka J, Nofziger J, Vanoni S, Stephan S, Silva ME, Meyer G, Paulmichl M: STAT6 links IL-4/IL-13 stimulation with pendrin expression in asthma and chronic obstructive pulmonary disease. Clin Pharmacol Ther 2011;90:399-405.
11. Pedemonte N, Caci E, Sondo E, Caputo A, Rhoden K, Pfeffer U, Di Candia M, Bandettini R, Ravazzolo R, Zegarra-Moran O, Galietta LJ: Thiocyanate transport in resting and IL-4-stimulated human bronchial epithelial cells: Role of pendrin and anion channels. J Immunol 2007;178:5144-5153. (Pubitemid 46595298)
12. Rillema JA, Hill MA: Pendrin transporter carries out iodide uptake into MCF-7 human mammary cancer cells. Exp Biol Med (Maywood) 2003;228:1078-1082. (Pubitemid 37222179)
13. Bidart JM, Lacroix L, Evain-Brion D, Caillou B, Lazar V, Frydman R, Bellet D, Filetti S, Schlumberger M: Expression of Na+/I-symporter and Pendred syndrome genes in trophoblast cells. J Clin Endocrinol Metab 2000;85:4367-4372. (Pubitemid 32055400)
14. Suzuki K, Royaux IE, Everett LA, Mori-Aoki A, Suzuki S, Nakamura K, Sakai T, Katoh R, Toda S, Green ED, Kohn LD: Expression of PDS/pds, the Pendred syndrome gene, in endometrium. J Clin Endocrinol Metab 2002;87:938-941. (Pubitemid 34158274)
15. Alesutan I, Pelzl L, C L, Voelkl J, Nofziger C, Dossena S, Paulmichl M, Lang F: Impact of bicarbonate, ammonium chloride, and acetazolamide on hepatic and renal Slc26a4 transcription. Cell Physiol Biochem 2011;28:553-558.
16. Dror AA, Politi Y, Shahin H, Lenz DR, Dossena S, Nofziger C, Fuchs H, Hrabe de Angelis M, Paulmichl M, Weiner S, Avraham KB: Calcium oxalate stone formation in the inner ear as a result of an Slc26a4 mutation. J Biol Chem 2010;285:21724-21735.
17. Everett LA, Belyantseva IA, Noben-Trauth K, Cantos R, Chen A, Thakkar SI, Hoogstraten-Miller SL, Kachar B, Wu DK, Green ED: Targeted disruption of mouse pds provides insight about the inner-ear defects encountered in Pendred syndrome. Hum Mol Genet 2001;10:153-161. (Pubitemid 32098125)
18. Everett LA, Glaser B, Beck JC, Idol JR, Buchs A, Heyman M, Adawi F, Hazani E, Nassir E, Baxevanis AD, Sheffield VC, Green ED: Pendred syndrome is caused by mutations in a putative sulphate transporter gene (PDS). Nat Genet 1997;17:411-422. (Pubitemid 27518389)
19. Morgans ME, Trotter WR: Association of congenital deafness with goitre; the nature of the thyroid defect. Lancet 1958;1:607-609.
20. Izuhara K, Ohta S, Shiraishi H, Suzuki S, Taniguchi K, Toda S, Tanabe T, Yasuo M, Kubo K, Hoshino T, Aizawa H: The mechanism of mucus production in bronchial asthma. Curr Med Chem 2009;16:2867-2875.
21. Lewis CC, Yang JY, Huang X, Banerjee SK, Blackburn MR, Baluk P, McDonald DM, Blackwell TS, Nagabhushanam V, Peters W, Voehringer D, Erle DJ: Disease-specific gene expression profiling in multiple models of lung disease. Am J Respir Crit Care Med 2008;177:376-387. (Pubitemid 351317580)
22. The global burden of disease: 2004 update. Geneva, Switzerland, World Health Organization, 2008.
23. World health statistics 2008. Geneva, Switzerland, WHO Press, 2008.
24. Akinbami LJ, Moorman JE, Liu X: Asthma prevalence, health care use, and mortality: United States, 2005-2009. Natl Health Stat Report 2011:1-14.
25. "The costs of asthma", Asthma and Allergy Foundation 1992 and 1998 Study, 2000.
26. Silva GE, Sherrill DL, Guerra S, Barbee RA: Asthma as a risk factor for COPD in a longitudinal study. Chest 2004;126:59-65. (Pubitemid 38943118)
27. Han MK: Update in chronic obstructive pulmonary disease in 2010. Am J Respir Crit Care Med 2011;183:1311-1315.
28. Holgate ST: Pathophysiology of asthma: What has our current understanding taught us about new therapeutic approaches? J Allergy Clin Immunol 2011;122:495-505.
29. Scanlon PD: The pathogenesis and pathology of COPD: Identifying risk factors and improving morbidity and mortality. Advanced Studies in Medicine 2004;4:S744-749. (Pubitemid 40037000)
30. Chung KF, Adcock IM: Multifaceted mechanisms in COPD: Inflammation, immunity, and tissue repair and destruction. Eur Respir J 2008;31:1334-1356.
31. Turner J, Jones CE: Regulation of mucin expression in respiratory diseases. Biochem Soc Trans 2009;37:877-881.
32. Holgate ST: Pathogenesis of asthma. Clin Exp Allergy 2008;38:872-897.
33. Wills-Karp M, Luyimbazi J, Xu X, Schofield B, Neben TY, Karp CL, Donaldson DD: Interleukin-13: Central mediator of allergic asthma. Science 1998;282:2258-2261. (Pubitemid 29004074)
34. Mullings RE, Wilson SJ, Puddicombe SM, Lordan JL, Bucchieri F, Djukanovic R, Howarth PH, Harper S, Holgate ST, Davies DE: Signal transducer and activator of transcription 6 (STAT-6) expression and function in asthmatic bronchial epithelium. J Allergy Clin Immunol 2001;108:832-838. (Pubitemid 33096218)
35. Lee YC, Lee KH, Lee HB, Rhee YK: Serum levels of interleukins (IL)-4, IL-5, IL-13, and interferon-gamma in acute asthma. J Asthma 2001;38:665-671. (Pubitemid 33104247)
36. Matsumoto K, Taki F, Miura M, Matsuzaki M, Takagi K: Serum levels of soluble IL-2R, IL-4, and soluble Fc epsilon RII in adult bronchial asthma. Chest 1994;105:681-686. (Pubitemid 24088440)
37. ten Hacken NH, Oosterhoff Y, Kauffman HF, Guevarra L, Satoh T, Tollerud DJ, Postma DS: Elevated serum interferon-gamma in atopic asthma correlates with increased airways responsiveness and circadian peak expiratory flow variation. Eur Respir J 1998;11:312-316. (Pubitemid 28108341)
38. Joseph J, Benedict S, Al-sowaidi S, Joseph M, Zoubeidi T: Serum interleukin-13 levels are elevated in mild and moderate persistent asthma. The Internet Journal of Asthma, Allergy and Immunology 2005;4
39. Ohshima Y, Katamura K, Miura M, Mikawa H, Mayumi M: Serum levels of interleukin 4 and soluble CD23 in children with allergic disorders. Eur J Pediatr 1995;154:723-728.
40. Zheng KC, Nong DX, Morioka T, Todoriki H, Ariizumi M: Elevated interleukin-4 and interleukin-6 in rats sensitized with toluene diisocyanate. Ind Health 2001;39:334-339. (Pubitemid 33035591)
41. Zund G, Madara JL, Dzus AL, Awtrey CS, Colgan SP: Interleukin-4 and interleukin-13 differentially regulate epithelial chloride secretion. J Biol Chem 1996;271:7460-7464. (Pubitemid 26107018)
42. Danahay H, Atherton H, Jones G, Bridges RJ, Poll CT: Interleukin-13 induces a hypersecretory ion transport phenotype in human bronchial epithelial cells. Am J Physiol Lung Cell Mol Physiol 2002;282:L226-236. (Pubitemid 34654674)
43. Galietta LJ, Pagesy P, Folli C, Caci E, Romio L, Costes B, Nicolis E, Cabrini G, Goossens M, Ravazzolo R, Zegarra-Moran O: IL-4 is a potent modulator of ion transport in the human bronchial epithelium in vitro. J Immunol 2002;168:839-845. (Pubitemid 34049586)
44. Woodruff PG, Boushey HA, Dolganov GM, Barker CS, Yang YH, Donnelly S, Ellwanger A, Sidhu SS, Dao-Pick TP, Pantoja C, Erle DJ, Yamamoto KR, Fahy JV: Genome-wide profiling identifies epithelial cell genes associated with asthma and with treatment response to corticosteroids. Proc Natl Acad Sci USA 2007;104:15858-15863. (Pubitemid 350035389)
45. Zhou Y, Dong Q, Louahed J, Dragwa C, Savio D, Huang M, Weiss C, Tomer Y, McLane MP, Nicolaides NC, Levitt RC: Characterization of a calciumactivated chloride channel as a shared target of Th2 cytokine pathways and its potential involvement in asthma. Am J Respir Cell Mol Biol 2001;25:486-491. (Pubitemid 33037681)
46. Merves M, Krane CM, Dou H, Greinwald JH, Menon AG, Choo D: Expression of aquaporin 1 and 5 in the developing mouse inner ear and audiovestibular assessment of an AQP5 null mutant. J Assoc Res Otolaryngol 2003;4:264-275. (Pubitemid 36753773)
47. Wang K, Feng YL, Wen FQ, Chen XR, Ou XM, Xu D, Yang J, Deng ZP: Decreased expression of human aquaporin-5 correlated with mucus overproduction in airways of chronic obstructive pulmonary disease. Acta Pharmacol Sin 2007;28:1166-1174. (Pubitemid 47197779)
48. Shen Y, Wang Y, Chen Z, Wang D, Wang X, Jin M, Bai C: Role of aquaporin 5 in antigen-induced airway inflammation and mucous hyperproduction in mice. J Cell Mol Med 2011;15:1355-1363.
49. Garnett JP, Hickman E, Burrows R, Hegyi P, Tiszlavicz L, Cuthbert AW, Fong P, Gray MA: Novel role for pendrin in orchestrating bicarbonate secretion in CFTR-expressing airway serous cells. J Biol Chem 2011; in press.
50. Schindler U, Wu P, Rothe M, Brasseur M, McKnight SL: Components of a Stat recognition code: Evidence for two layers of molecular selectivity. Immunity 1995;2:689-697.
51. Lappalainen U, Whitsett JA, Wert SE, Tichelaar JW, Bry K: Interleukin-1beta causes pulmonary inflammation, emphysema, and airway remodeling in the adult murine lung. Am J Respir Cell Mol Biol 2005;32:311-318. (Pubitemid 40478306)
52. Harper RW, Xu C, Eiserich JP, Chen Y, Kao CY, Thai P, Setiadi H, Wu R: Differential regulation of dual NADPH oxidases/peroxidases, duox1 and duox2, by Th1 and Th2 cytokines in respiratory tract epithelium. FEBS Lett 2005;579:4911-4917. (Pubitemid 41218684)
53. Rada B, Lekstrom K, Damian S, Dupuy C, Leto TL: The pseudomonas toxin pyocyanin inhibits the dual oxidase-based antimicrobial system as it imposes oxidative stress on airway epithelial cells. J Immunol 2008;181:4883-4893.
54. Mullane K: Asthma translational medicine: Report card. Biochem Pharmacol 2011;82:567-585.
55. Barnes PJ: New therapies for asthma: Is there any progress? Trends Pharmacol Sci 2010;31:335-343.
56. Wenzel S, Wilbraham D, Fuller R, Getz EB, Longphre M: Effect of an interleukin-4 variant on late phase asthmatic response to allergen challenge in asthmatic patients: Results of two phase 2a studies. Lancet 2007;370:1422-1431. (Pubitemid 47576168)
57. McCusker CT, Wang Y, Shan J, Kinyanjui MW, Villeneuve A, Michael H, Fixman ED: Inhibition of experimental allergic airways disease by local application of a cell-penetrating dominant-negative STAT-6 peptide. J Immunol 2007;179:2556-2564.
58. Kinyanjui MW, Fixman ED: Cell-penetrating peptides and proteins: New inhibitors of allergic airways disease. Can J Physiol Pharmacol 2008;86:1-7. (Pubitemid 351281097)
59. Healey GD, Zinnen S, Lockridge JA, Richards I, Evans N, Walker W: Identification of small interfering RNA targeting signal transducer and activator of transcription 6: Characterisation and selection of candidates for pre-clinical development. J RNAi Gene Silencing 2010;6:401-410.
60. Chiba Y, Todoroki M, Nishida Y, Tanabe M, Misawa M: A novel STAT6 inhibitor AS1517499 ameliorates antigen-induced bronchial hypercontractility in mice. Am J Respir Cell Mol Biol 2009;41:516-524.
61. Holmes AM, Solari R, Holgate ST: Animal models of asthma: Value, limitations and opportunities for alternative approaches. Drug Discov Today 2011;16:659-670.
62. Canning BJ: Modeling asthma and COPD in animals: A pointless exercise? Curr Opin Pharmacol 2003;3:244-250. (Pubitemid 36686763)
63. Corren J, Lemanske RF, Hanania NA, Korenblat PE, Parsey MV, Arron JR, Harris JM, Scheerens H, Wu LC, Su Z, Mosesova S, Eisner MD, Bohen SP, Matthews JG: Lebrikizumab treatment in adults with asthma. N Engl J Med 2011;365:1088-1098.
64. Bai TR, Knight DA: Structural changes in the airways in asthma: Observations and consequences. Clinical Science 2005;108:463-477. (Pubitemid 40827554)
65. Baraldo S, Turato G, Bazzan E, Ballarin A, Damin M, Balestro E, Oliani KL, Calabrese F, Maestrelli P, Snijders D, Barbato A, Saetta M: Non-eosinophilic asthma in children: Relation with airway remodeling. Eur Respir J 2011;38:575-583.
66. Barbato A, Turato G, Baraldo S, Bazzan E, Calabrese F, Panizzolo C, Zanin ME, Zuin R, Maestrelli P, Fabbri LM, Saetta M: Epithelial damage and angiogenesis in the airways of children with asthma. Am J Respir Crit Care Med 2006;174:975-981. (Pubitemid 44684445)
67. Holgate ST: The sentinel role of the airway epithelium in asthma pathogenesis. Immunol Rev 2011;242:205-219.
68. Dossena S, Vezzoli V, Cerutti N, Bazzini C, Tosco M, Sironi C, Rodighiero S, Meyer G, Fascio U, J FUR, Ritter M, Fugazzola L, Persani L, Zorowka P, Storelli C, Peccoz PB, Botta G, Paulmichl M: Functional characterization of wild-type and a mutated form of SLC26A4 identified in a patient with Pendred syndrome. Cell Physiol Biochem 2006;17:245-256. (Pubitemid 43946280)
69. Nakano T, Inoue H, Fukuyama S, Matsumoto K, Matsumura M, Tsuda M, Matsumoto T, Aizawa H, Nakanishi Y: Niflumic acid suppresses interleukin-13-induced asthma phenotypes. Am J Respir Crit Care Med 2006;173:1216-1221. (Pubitemid 43848391)
70. Madeo AC, Manichaikul A, Pryor SP, Griffith AJ: Do mutations of the Pendred syndrome gene, SLC26A4, confer resistance to asthma and hypertension? J Med Genet 2009;46:405-406.